Bruce D Hammock

USPTO Granted Patents = 73 (Patent Applications = 19)

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 426(Granted Patents)

Inventors with similar research interests:

Location History:

David, CA (US) (2018)
Davis, CA (US) (1985 - 2024)

Company Filing History:

67 out of 15,458

University of California

Burnham Institute for Medical Research

University of Massachusetts

patents

7. 1 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

8. 1 out of 1

Goethe-university Frankfurt

patent

9. 1 out of 889

The United States Government As Represented by the Department of Veterans Affairs

patents

10. 1 out of 262

Massachusetts Eye and Ear Infirmary

patents

11. 1 out of 99

Sanford-burnham Medical Research Institute

patents

12. 1 out of 516

Beth Israel Deaconess Medical Center, Inc.

patents

13. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2025

Loading Chart...

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12485107 - Methods for the prevention or treatment of cytokine storm (2025-12-02),

2. 12357598 - Treatment of neurodevelopmental disorders (2025-07-15),

3. 12251379 - Methods of inhibiting formation of alpha synuclein aggregates (2025-03-18),

4. 12006355 - Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif) (2024-06-11),

5. 11987542 - Co-crystal of sorafenib derivatives and process for preparation thereof (2024-05-21),

6. 11873288 - Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) (2024-01-16),

7. 11723929 - Methods of improving cell-based therapy (2023-08-15),

8. 11690837 - Methods of improving cell-based therapy (2023-07-04),

9. 11572347 - Orally available sEH/PDE4 dual inhibitors (2023-02-07),

10. 11426385 - Methods of improving cancer chemotherapy (2022-08-30),

11. 11225514 - Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif) (2022-01-18),

12. 11123311 - Methods of treating mental disorders (2021-09-21),

13. 11001783 - Synthesis and use of ω-hydroxylated polyunsaturated fatty acids (2021-05-11),

14. 10858338 - Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH) (2020-12-08),

15. 10813894 - Methods of inhibiting pain (2020-10-27),

Title: The Innovative Journey of Bruce D Hammock

Introduction: Bruce D Hammock, a distinguished inventor hailing from Davis, California, has made significant contributions to the field of innovations and patents.

Latest Patents: Bruce D Hammock has been actively involved in the creation of cutting-edge patents, with his latest inventions focusing on biochemistry and environmental science.

Career Highlights: Throughout his illustrious career, Bruce D Hammock has garnered recognition for his groundbreaking work in developing novel technologies aimed at improving human health and environmental sustainability. His patents have revolutionized various industries, showcasing his versatility and ingenuity.

Collaborations: Bruce D Hammock has collaborated with leading researchers, scientists, and institutions worldwide to further advance his innovative ideas and bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of scientific discovery.

Conclusion: In conclusion, Bruce D Hammock stands as a trailblazing inventor whose relentless pursuit of innovation has left an indelible mark on the world of patents and inventions. His dedication to creating transformative technologies continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.